J. Goldman & Co LP

13F Holdings History for Eagle Pharmaceuticals, Inc. - Common stock, $0.001 par value per share (EGRX)

Symbol: EGRX
Investment type: Equity / Common stock, $0.001 par value per share
Latest Disclosed Ownership: 667K shares
Security Ownership: 5.1%

Shares, Excluding Options vs Price

Value, Excluding Options

J. Goldman & Co LP ownership in Eagle Pharmaceuticals, Inc. Common stock, $0.001 par value per share (EGRX)

2025-08-14 - J. Goldman & Co LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 667K shares of Eagle Pharmaceuticals, Inc. Common stock, $0.001 par value per share (EGRX). This represents 5.1% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
J. Goldman & Co LP	5.1%		$1.93M	667K			$2.90	13G	6/30/2025	14 Aug 2025 20:08:15

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024			-0.02%	$0	0	-150,611	-100%		Q4 2024
9/30/2024		0.02%	-0.01%	$562K	151K	-40,500	-21.2%	$3.73	Q3 2024
6/30/2024		0.04%	-0.02%	$1.07M	191K	-67,585	-26.1%	$5.60	Q2 2024
3/31/2024		0.06%	+0%	$1.36M	259K	+12,271	+4.98%	$5.24	Q1 2024
3/31/2024	call		-0.03%	$0	0	-87,500	-100%		Q1 2024
12/31/2023		0.07%	+0.05%	$1.29M	246K	+246,425	NEW	$5.23	Q4 2023
12/31/2023	call	0.03%	+0.02%	$458K	87.5K	+87,500	NEW	$5.23	Q4 2023
3/31/2022			-0.21%	$0	0	-75,646	-100%		Q1 2022
12/31/2021		0.21%	+0.13%	$3.85M	75.6K	+47,118	+165%	$50.92	Q4 2021
9/30/2021		0.14%	+0.06%	$1.59M	28.5K	+28,528	NEW	$55.77	Q3 2021
6/30/2016			0%	$0	0	-1,700	-100%		Q2 2016
6/30/2016	call		-0.14%	$0	0	-55,000	-100%		Q2 2016
3/31/2016		0%	+0%	$69K	1.7K	+1,700	NEW	$40.59	Q1 2016
3/31/2016	call	0.14%	+0.14%	$2.23M	55K	+55,000	NEW	$40.51	Q1 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.